Clinical Trial Update: A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine. [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed the effectiveness of Lavoltidine (AH234844) compared with Nexium (esomeprazole) and ranitidine for gastroesophageal reflux disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Lavoltidine (lavoltidine)
• Nexium (esomeprazole)
• Ranitidine (Ranitidine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Gastroesophageal Reflux Disease, Reflux, Gastroesophageal | Phase 2 | Status: COMPLETED